FDA 483 - Consumer Product Partners, LLC - June 14, 2023

Vi-Jon, LLC, a human drug manufacturer in Saint Louis, MO, was cited for significant deficiencies across four observations. The inspection revealed failures in preventing microbial contamination, thoroughly investigating discrepancies, adhering to quality unit responsibilities, and following procedures for component handling and testing. These issues indicate a systemic breakdown in quality control and manufacturing practices.